Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
RedShiftBio logo — See Change

RedShiftBio

See Change

Founded 2005 United States United States 31 employees Series E Total: $65.75M Biotechnology, Design +3

General Information

Company Name RedShiftBio
Founded Year 2005
Location United States United States
Employees 31
Industries Biotechnology, Design, Enterprise Software +2
Funding Stage Series E
Social

BounceWatch is an independent company data service, not affiliated with RedShiftBio. To contact RedShiftBio, visit redshiftbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does RedShiftBio compare?

A PDF of RedShiftBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting RedShiftBio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About RedShiftBio

RedShiftBio, with the slogan "See Change," is revolutionizing protein structure and concentration analysis. The company's proprietary life sciences platform utilizes Microfluidic Modulation Spectroscopy (MMS) and high-powered quantum cascade lasers to deliver precise measurements of molecular structure. This technology, available in the fully-automated Aurora and Apollo systems, is essential for assessing the safety, efficacy, and stability of biomolecules and their raw materials. RedShiftBio also provides support to biopharmaceutical manufacturing through HaLCon, a bioprocess analytics platform designed to measure protein titer at the time of need. Established in 2005 and headquartered in the United States, the company boasts an experienced management team and collaborates with prominent industry leaders. RedShiftBio's global impact is evident through its presence in leading biopharmaceutical companies and CDMOs worldwide and its collaborative centers in different locations including Boxborough, MA, Oxford, UK, Brussels, Belgium, and Redwood Shores, CA. The company has secured a significant $20.00M Series E investment on 18 October 2021, with backing from Waters Corporation, Illumina Ventures, and Technology Venture Partners. Additionally, an undisclosed leading life science company has contributed to the company's success. RedShiftBio's innovative approach, strong investor support, and commitment to advancing research, development, and manufacturing make it a promising player in the Biotechnology, Enterprise Software, and Manufacturing industries.

Business keywords: biopharmaceuticals, protein analysis, bioprocess analytics, spectroscopy, quantum cascade lasers, molecular structure, instrumentation, biomolecule stability, biopharmaceutical manufacturing, microfluidic modulation spectroscopy, technology, venture capital, innovation

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series E $20.00M 3
Illumina Ventures Technology Venture Partners
Illumina Ventures, Technology Venture Partners +1
18 Oct 2021
Series D $18.00M 1
Waters Corporation
29 Jan 2020
Series C $11.00M 2
Technology Venture Partners
Technology Venture Partners, Waters Corporation
14 Mar 2017
Venture Round $998.14K -
02 Oct 2015
Venture Round $751.55K -
03 Apr 2014
Series B $3.00M 1
Technology Venture Partners
Technology Venture Partners
11 Apr 2013
Series A $12.00M 6
InterWest Partners Alta Partners Technology Venture Partners
InterWest Partners, Alta Partners +4
12 Jan 2006

RedShiftBio Alternatives & Competitors

RedShiftBio vs
PAK BioSolutions
PAK BioSolutions United States

Driving Advancements in Biopharmaceutical Manufacturing

Non Equity Assistance
7 employees
Biotechnology, Manufacturing
Compare RedShiftBio vs PAK BioSolutions

FAQ About RedShiftBio

See Change
RedShiftBio was founded in 2005.
RedShiftBio is headquartered in United States.
RedShiftBio operates in Biotechnology, Design, Enterprise Software, Life Sciences and Manufacturing. Its work centres on biopharmaceuticals, protein analysis, bioprocess analytics and spectroscopy.
RedShiftBio has approximately 31 employees.
RedShiftBio has completed 7 funding rounds, raising a total of $65.75M. The latest funding stage is Series E.
Top alternatives and competitors to RedShiftBio include PAK BioSolutions. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RedShiftBio and PAK BioSolutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for RedShiftBio, https://www.bouncewatch.com/company/redshiftbio, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout